When the cure becomes the curse: Radiation-induced glioma of the pons in children surviving craniopharyngioma.

IF 2.5 Q2 CLINICAL NEUROLOGY
Neuro-oncology practice Pub Date : 2026-02-27 eCollection Date: 2026-08-01 DOI:10.1093/nop/npag018
Rahat Ul Ain, Hamza S Gorsi, Celine Habre, Andrea Bartoli, Sebastien Tran, Rabia A Qaiser, Laeeq Ur Rehman, Steven R Miller, Eric Bouffet, André O von Bueren
{"title":"When the cure becomes the curse: Radiation-induced glioma of the pons in children surviving craniopharyngioma.","authors":"Rahat Ul Ain, Hamza S Gorsi, Celine Habre, Andrea Bartoli, Sebastien Tran, Rabia A Qaiser, Laeeq Ur Rehman, Steven R Miller, Eric Bouffet, André O von Bueren","doi":"10.1093/nop/npag018","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The standard of care for pediatric craniopharyngioma (CP) is either complete surgical resection or limited debulking surgery followed by adjuvant radiotherapy (RT). Recent data favor the latter approach.</p><p><strong>Methods: </strong>We present a multi-center case series of three children with CP treated with subtotal surgery and adjuvant RT for CP who eventually developed radiation-induced glioma (RIG) of the pons.</p><p><strong>Results: </strong>The median age at diagnosis of CP was 6 years. Photon RT was administered in two patients and proton RT in one, at a median dose of 54 Gy delivered in 30 fractions. Pontine glioma was first identified on imaging after a median interval of 8 years from initial RT (range 4.5 - 9.75 years), incidentally in two asymptomatic patients during routine surveillance, and associated with symptoms of brainstem involvement in one. A biopsy was performed in two patients. One showed diffuse astrocytoma with <i>MYCN</i>, <i>PDGFRA</i>, and <i>MDM2</i> amplification and a novel fusion (RBD7-FLI1), while the other case had an inconclusive histopathology. Re-irradiation (re-RT) (54 Gy/30 fractions and 30 Gy/10 fractions) was applied in two patients, and one patient received bevacizumab treatment. All three patients succumbed with a median survival of 7.5 months (range 4.0-58 months).</p><p><strong>Conclusions: </strong>Radiation-induced glioma of the pons is a rare and serious complication occurring in patients previously treated by RT for childhood CP. This secondary tumor is uniformly associated with a dramatic course regardless of the treatment modalities and resources. This highlights the need for clinical vigilance and further research to prevent it.</p>","PeriodicalId":19234,"journal":{"name":"Neuro-oncology practice","volume":"13 4","pages":"816-822"},"PeriodicalIF":2.5000,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13365136/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npag018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The standard of care for pediatric craniopharyngioma (CP) is either complete surgical resection or limited debulking surgery followed by adjuvant radiotherapy (RT). Recent data favor the latter approach.

Methods: We present a multi-center case series of three children with CP treated with subtotal surgery and adjuvant RT for CP who eventually developed radiation-induced glioma (RIG) of the pons.

Results: The median age at diagnosis of CP was 6 years. Photon RT was administered in two patients and proton RT in one, at a median dose of 54 Gy delivered in 30 fractions. Pontine glioma was first identified on imaging after a median interval of 8 years from initial RT (range 4.5 - 9.75 years), incidentally in two asymptomatic patients during routine surveillance, and associated with symptoms of brainstem involvement in one. A biopsy was performed in two patients. One showed diffuse astrocytoma with MYCN, PDGFRA, and MDM2 amplification and a novel fusion (RBD7-FLI1), while the other case had an inconclusive histopathology. Re-irradiation (re-RT) (54 Gy/30 fractions and 30 Gy/10 fractions) was applied in two patients, and one patient received bevacizumab treatment. All three patients succumbed with a median survival of 7.5 months (range 4.0-58 months).

Conclusions: Radiation-induced glioma of the pons is a rare and serious complication occurring in patients previously treated by RT for childhood CP. This secondary tumor is uniformly associated with a dramatic course regardless of the treatment modalities and resources. This highlights the need for clinical vigilance and further research to prevent it.

当治愈成为诅咒:儿童脑桥放射性胶质瘤存活颅咽管瘤。
背景:儿童颅咽管瘤(CP)的标准治疗是完全手术切除或有限减容手术加辅助放疗(RT)。最近的数据支持后一种方法。方法:我们提出了一个多中心的病例系列,其中三名儿童CP接受了次全手术和辅助RT治疗,最终发展为脑桥放射性胶质瘤(RIG)。结果:CP的中位诊断年龄为6岁。2例患者接受光子放射治疗,1例患者接受质子放射治疗,中位剂量为54 Gy,分30次给予。脑桥胶质瘤首次在影像学上被发现,中位时间间隔为8年(范围4.5 - 9.75年),在常规监测中偶然发现2例无症状患者,1例伴有脑干受累症状。两名患者进行了活组织检查。一例表现为弥漫性星形细胞瘤,伴有MYCN、PDGFRA和MDM2扩增和新的融合(RBD7-FLI1),而另一例的组织病理学不确定。2例患者应用再照射(re-RT) (54 Gy/30分和30 Gy/10分),1例患者接受贝伐单抗治疗。3例患者均死亡,中位生存期为7.5个月(范围4.0-58个月)。结论:放射诱导的脑桥胶质瘤是一种罕见且严重的并发症,发生在以前接受过RT治疗的儿童CP患者中。无论治疗方式和资源如何,这种继发性肿瘤均与戏剧性病程相关。这突出了临床警惕和进一步研究以预防它的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuro-oncology practice
Neuro-oncology practice CLINICAL NEUROLOGY-
CiteScore
5.30
自引率
11.10%
发文量
92
期刊介绍: Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书